Blood compatibility evaluation of polydopamine nanoparticles
The findings offer important insights into the hemocompatibility of PDA NPs, which is essential for their safe and effective clinical use. Understanding their interactions with blood components is key to ensuring their compatibility in biomedical applications. These results are vital for guiding the development of PDA NPs for medical use, particularly in blood-contacting applications.
Authors
- Xiao-Yan Yang (ORCID: https://orcid.org/0000-0002-0957-759X)
- Sha Li (ORCID: https://orcid.org/0000-0002-6477-4537)
- Zhong Guo (ORCID: https://orcid.org/0000-0002-4443-9360)
- Si-Ming Yan
- Liwei Zhang (ORCID: https://orcid.org/0000-0002-9247-6334)
Institutions
- Zunyi Medical University (CN)
- Beijing Normal University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-02-28
- DOI
- https://doi.org/10.3389/fphar.2025.1530650
- Citations
- 7
- Primary Topic
- Polymer Surface Interaction Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.63